Table 1 The clinical and molecular characteristics of glioma in three independent datasets
From: LncRNA-PVT1 was identified as a key regulator for TMZ resistance and STAT-related pathway in glioma
CGGA dataset (n = 325) | TCGA dataset (n = 627) | GSE16011 (n = 258) | |
|---|---|---|---|
Age | |||
≤40 years | 138 | 242 | 71 |
>40 years | 187 | 385 | 187 |
Gender | |||
Male | 203 | 363 | 180 |
Female | 122 | 264 | 78 |
WHO grade | |||
Grade II | 109 | 221 | 23 |
Grade III | 72 | 245 | 84 |
Grade IV | 144 | 161 | 151 |
IDH Status | |||
Mutant | 167 | 390 | 77 |
Wild-type | 158 | 237 | 130 |
1p/19q Status | |||
Codel | 64 | 154 | 48 |
Intact | 261 | 457 | 104 |
Molecular subtype | |||
Proneural | 102 | 136 | 91 |
Neural | 81 | 71 | 26 |
Classical | 74 | 83 | 57 |
Mesenchymal | 68 | 92 | 84 |